A synthetic strategy to pyrrolo[2,1-f][1,2,4]triazines is reported. We show that various synthetically easily accessible 1,2,4-triazines can be efficiently alkylated under mild conditions to provide the corresponding 1-alkyl-1,2,4-triazinium salts. These bench-stable salts serve as precursors to triazinium ylides, which react in 1,3-dipolar cycloadditions with electron-poor dipolarophiles to yield polysubstituted pyrrolotriazines in a single step.

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo nám 2 Prague 16000 Czech Republic

Zobrazit více v PubMed

Dzierba Carolyn D.; Dasgupta B.; Macor John E.; Bronson Joanne J.; Rajamani R.; Karageorge George N.. Pyrrolotriazine Kinase Inhibitors. WO 2015054358 A1, 2014/10/08, 2015.

Kim In W. O. O.; Yoo Ja K.; Kim Ji D.; Jun Sun A. H.; Lee Jun H. E.. Pyrrolotriazine Derivatives As Kinase Inhibitor. WO 2018169373 A1, 2018/03/19, 2018.

Liang C.; Jia M.; Tian D.; Sun H. A. N.. Synthesis And Medical Application Of Pyrrolo-[2,1-

Ott G. R.; Favor D. A. Pyrrolo[2,1- PubMed DOI

Yang C.; Meng L.; Chen Y.; Wang X.; Tan C. U. N.; Li J.; Ding J.; Chen Y. I.. Pyrrolo[2,1-

Tyndall E. M.; Draffan A. G.; Frey B.; Pool B.; Halim R.; Jahangiri S.; Bond S.; Wirth V.; Luttick A.; Tilmanis D.; Thomas J.; Porter K.; Tucker S. P. Prodrugs of imidazotriazine and pyrrolotriazine C-nucleosides can increase anti-HCV activity and enhance nucleotide triphosphate concentrations in vitro. Bioorg. Med. Chem. Lett. 2015, 25, 869–873. 10.1016/j.bmcl.2014.12.069. PubMed DOI

Mesaros E. F.; Angeles T. S.; Albom M. S.; Wagner J. C.; Aimone L. D.; Wan W.; Lu L.; Huang Z.; Olsen M.; Kordwitz E.; Haltiwanger R. C.; Landis A. J.; Cheng M.; Ruggeri B. A.; Ator M. A.; Dorsey B. D.; Ott G. R. Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1- PubMed DOI

Lim J.; Altman M. D.; Baker J.; Brubaker J. D.; Chen H.; Chen Y.; Kleinschek M. A.; Li C.; Liu D.; Maclean J. K. F.; Mulrooney E. F.; Presland J.; Rakhilina L.; Smith G. F.; Yang R. Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modifications. Bioorg. Med. Chem. Lett. 2015, 25, 5384–5388. 10.1016/j.bmcl.2015.09.028. PubMed DOI

Neunhoeffer H.; Lehmann B. Cycloadditionen mit Azabenzolen, XI. Cycloadditionen mit Methoxy- und Dialkylamino-1,2,4-triazinen. Justus Liebigs Ann. Chem. 1977, 1977, 1413–1420. 10.1002/jlac.197719770902. DOI

Migliara O.; Petruso S.; Sprio V. Synthesis of a new bridgehead nitrogen heterocyclic system. Pyrrolo [2,1- DOI

Maeba I.; Hayashi M.; Araki A. C-Nucleosides A Synthesis of 2-Substituted 7-(β-D-Ribofuranosyl)pyrrolo[2,1- DOI

Patil S. A.; Otter B. A.; Klein R. S. Synthesis of pyrrolo[2,1- DOI

Patil S. A.; Otter B. A.; Klein R. S. 4-aza-7,9-dideazaadenosine, a new cytotoxic synthetic C-nucleoside analogue of adenosine. Tetrahedron Lett. 1994, 35, 5339–5342. 10.1016/s0040-4039(00)73494-0. DOI

Hunt J. T.; Mitt T.; Borzilleri R.; Gullo-Brown J.; Fargnoli J.; Fink B.; Han W.-C.; Mortillo S.; Vite G.; Wautlet B.; Wong T.; Yu C.; Zheng X.; Bhide R. Discovery of the Pyrrolo[2,1- PubMed DOI

Borzilleri R. M.; Cai Z.-w.; Ellis C.; Fargnoli J.; Fura A.; Gerhardt T.; Goyal B.; Hunt J. T.; Mortillo S.; Qian L.; Tokarski J.; Vyas V.; Wautlet B.; Zheng X.; Bhide R. S. Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1- PubMed DOI

Cai Z.-w.; Wei D.; Borzilleri R. M.; Qian L.; Kamath A.; Mortillo S.; Wautlet B.; Henley B. J.; Jeyaseelan R.; Tokarski J.; Hunt J. T.; Bhide R. S.; Fargnoli J.; Lombardo L. J. Synthesis, SAR, and Evaluation of 4-[2,4-Difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1- PubMed DOI

Gavai A. V.; Fink B. E.; Fairfax D. J.; Martin G. S.; Rossiter L. M.; Holst C. L.; Kim S.-H.; Leavitt K. J.; Mastalerz H.; Han W.-C.; Norris D.; Goyal B.; Swaminathan S.; Patel B.; Mathur A.; Vyas D. M.; Tokarski J. S.; Yu C.; Oppenheimer S.; Zhang H.; Marathe P.; Fargnoli J.; Lee F. Y.; Wong T. W.; Vite G. D. Discovery and Preclinical Evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1- PubMed DOI

Schroeder G. M.; Chen X.-T.; Williams D. K.; Nirschl D. S.; Cai Z.-W.; Wei D.; Tokarski J. S.; An Y.; Sack J.; Chen Z.; Huynh T.; Vaccaro W.; Poss M.; Wautlet B.; Gullo-Brown J.; Kellar K.; Manne V.; Hunt J. T.; Wong T. W.; Lombardo L. J.; Fargnoli J.; Borzilleri R. M. Identification of pyrrolo[2,1- PubMed DOI

Thieu T.; Sclafani J. A.; Levy D. V.; McLean A.; Breslin H. J.; Ott G. R.; Bakale R. P.; Dorsey B. D. Discovery and Process Synthesis of Novel 2,7-Pyrrolo[2,1- PubMed DOI

Hodous Brian L.; Wilson Kevin J.; Zhang Y.. Compositions Useful For Treating Disorders Related To Kit And Pdfgr. U.S. Patent 20,170,022,206 A1, 2016/07/22, 2017.

Cascioferro S.; Parrino B.; Spanò V.; Carbone A.; Montalbano A.; Barraja P.; Diana P.; Cirrincione G. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds. Eur. J. Med. Chem. 2017, 142, 328–375. 10.1016/j.ejmech.2017.08.009. PubMed DOI

Xin M.; Zhang L.; Tang F.; Tu C.; Wen J.; Zhao X.; Liu Z.; Cheng L.; Shen H. Design, synthesis, and evaluation of pyrrolo[2,1-f][1,2,4]triazine derivatives as novel hedgehog signaling pathway inhibitors. Bioorg. Med. Chem. 2014, 22, 1429–1440. 10.1016/j.bmc.2013.12.055. PubMed DOI

Song Y. n.; Zhan P.; Zhang Q.; Liu X. Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistry. Curr. Pharm. Des. 2013, 19, 1528–1548. 10.2174/1381612811319080020. PubMed DOI

Paymode D. J.; Cardoso F. S. P.; Agrawal T.; Tomlin J. W.; Cook D. W.; Burns J. M.; Stringham R. W.; Sieber J. D.; Gupton B. F.; Snead D. R. Expanding Access to Remdesivir via an Improved Pyrrolotriazine Synthesis: Supply Centered Synthesis. Org. Lett. 2020, 22, 7656–7661. 10.1021/acs.orglett.0c02848. PubMed DOI PMC

Chupakhin O. N.; Rudakov B. V.; Alexeev S. G.; Shorshnev S. V.; Charushin V. N. 1-Alkyl-1,2,4-triazinium Ylides as 1,3-Dipoles in a Cycloaddition Reaction with Diethyl Acetylenedicarboxylate. Mendeleev Commun. 1992, 2, 85–86. 10.1070/mc1992v002n03abeh000144. DOI

Crespin L.; Biancalana L.; Morack T.; Blakemore D. C.; Ley S. V. One-Pot Acid-Catalyzed Ring-Opening/Cyclization/Oxidation of Aziridines with N-Tosylhydrazones: Access to 1,2,4-Triazines. Org. Lett. 2017, 19, 1084–1087. 10.1021/acs.orglett.7b00101. PubMed DOI

Shi B.; Lewis W.; Campbell I. B.; Moody C. J. A Concise Route to Pyridines from Hydrazides by Metal Carbene N–H Insertion, 1,2,4-Triazine Formation, and Diels–Alder Reaction. Org. Lett. 2009, 11, 3686–3688. 10.1021/ol901502u. PubMed DOI

Meng J.; Wen M.; Zhang S.; Pan P.; Yu X.; Deng W.-P. Unexpected O–H Insertion of Rhodium-Azavinylcarbenes with N-Acylhydrazones: Divergent Synthesis of 3,6-Disubstituted- and 3,5,6-Trisubstituted-1,2,4-Triazines. J. Org. Chem. 2017, 82, 1676–1687. 10.1021/acs.joc.6b02846. PubMed DOI

Lukin A.; Vedekhina T.; Tovpeko D.; Zhurilo N.; Krasavin M. Zn-catalyzed hydrohydrazination of propargylamides with BocNHNH DOI

Zhu Z.; Glinkerman C. M.; Boger D. L. Selective N1/N4 1,4-Cycloaddition of 1,2,4,5-Tetrazines Enabled by Solvent Hydrogen Bonding. J. Am. Chem. Soc. 2020, 142, 20778–20787. 10.1021/jacs.0c09775. PubMed DOI PMC

Tang D.; Wang J.; Wu P.; Guo X.; Li J.-H.; Yang S.; Chen B.-H. Synthesis of 1,2,4-triazine derivatives via [4 + 2] domino annulation reactions in one pot. RSC Adv. 2016, 6, 12514–12518. 10.1039/c5ra26638f. DOI

Yamanaka H; Konno S.; Sagi M.; Yoshida N.; Yamanaka H. Studies on as-Triazine Derivatives .X. Addition-Reaction of Phenylmagnesium Bromide with 1,2,4-Triazines. Heterocycles 1987, 26, 3111–3114. 10.3987/R-1987-12-3111. DOI

Alphonse F.-A.; Suzenet F.; Keromnes A.; Lebret B.; Guillaumet G. A General Approach to Selective Functionalization of 1,2,4-Triazines Using Organometallics in Palladium-Catalyzed Cross-Coupling and Addition Reactions. Synthesis 2004, 2893–2899. 10.1055/s-2004-834868. DOI

Alphonse F.-A.; Suzenet F.; Keromnes A.; Lebret B.; Guillaumet G. Copper(I)-Promoted Palladium-Catalyzed Cross-Coupling of Unsaturated Tri- PubMed DOI

Finlay M. R. V.; Anderton M.; Bailey A.; Boyd S.; Brookfield J.; Cairnduff C.; Charles M.; Cheasty A.; Critchlow S. E.; Culshaw J.; Ekwuru T.; Hollingsworth I.; Jones N.; Leroux F.; Littleson M.; McCarron H.; McKelvie J.; Mooney L.; Nissink J. W. M.; Perkins D.; Powell S.; Quesada M. J.; Raubo P.; Sabin V.; Smith J.; Smith P. D.; Stark A.; Ting A.; Wang P.; Wilson Z.; Winter-Holt J. J.; Wood J. M.; Wrigley G. L.; Yu G.; Zhang P. Discovery of a Thiadiazole–Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models. J. Med. Chem. 2019, 62, 6540–6560. 10.1021/acs.jmedchem.9b00260. PubMed DOI

Shi D.-H.; Harjani J. R.; Gable R. W.; Baell J. B. Synthesis of 3-(Alkylamino)-, 3-(Alkoxy)-, 3-(Aryloxy)-, 3-(Alkylthio)-, and 3-(Arylthio)-1,2,4-triazines by Using a Unified Route with 3-(Methylsulfonyl)-1,2,4-triazine. Eur. J. Org. Chem. 2016, 2016, 2842–2850. 10.1002/ejoc.201600267. DOI

Chupakhin O. N.; Rudakov B. V.; McDermott P.; Alexeev S. G.; Charushin V. N.; Hegarty F. An Unusually Easy Oxidative Dequaternization of N-Alkyl-1,2,4-triazinium Salts. Mendeleev Commun. 1995, 5, 104–105. 10.1070/mc1995v005n03abeh000478. DOI

McCulloch A. W.; McInnes A. G. The Reaction of Propiolic Acid Esters with Tertiary Amines. Formation of Betaines. Can. J. Chem. 1974, 52, 3569–3576. 10.1139/v74-534. DOI

Synthesis of C3-Substituted N1-tert-Butyl 1,2,4-Triazinium Salts via the Liebeskind-Srogl Reaction for Fluorogenic Labeling of Live Cells